General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Total
Previously Reported [Member]
Common Stock
Common Stock
Previously Reported [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported [Member]
Accumulated Deficit
Accumulated Deficit
Previously Reported [Member]
Balance at the beginning at Dec. 31, 2020 $ (3,496,499)   $ 4   $ 2,044,372   $ (5,540,875)  
Balance at the beginning (in shares) at Dec. 31, 2020     35,592          
Share-based compensation 1,230,792       1,230,792      
Issuance of common stock upon exercise of stock options 61   $ 1   60      
Issuance of common stock upon exercise of stock options (in shares)     6,941          
Exchange of common shares of Marpai Health, Inc. (see Note 1) (14)   $ (4)   (10)      
Exchange of common shares of Marpai Health, Inc. (in shares)     (35,592)          
Issuance of common stock in connection with public offering, net [1] 17,351,935   $ 279   17,351,656      
Issuance of common stock in connection with public offering, net (in shares) [1]     2,786,826          
Issuance of common shares in connection with initial public offering, net 24,547,085   $ 180   24,546,905      
Issuance of common shares in connection with initial public offering, net (in shares)     1,796,875          
Conversion of convertible notes to common stock in connection with initial public offering 5,106,554   $ 42   5,106,512      
Conversion of convertible notes to common stock in connection with initial public offering (in shares)     428,040          
Exercise of warrant 900,000   $ 5   899,995      
Exercise of warrant (in shares)     56,250          
Warrants issued for cash 53,333       53,333      
Net loss (15,984,835)           (15,984,835)  
Balance at the end at Dec. 31, 2021 $ 29,708,412   $ 506 $ 507 51,233,616 $ 51,233,615 (21,525,710)  
Balance at the end (in shares) at Dec. 31, 2021 5,074,932   5,074,932 [2]          
Share-based compensation $ 1,493,351       1,493,351      
Issuance of common stock upon vesting of restricted stock units 9   $ 9          
Issuance of common stock upon vesting of restricted stock units (in shares) [2]     90,154          
Common Stock issued to vendors in exchange for services 23,173       23,173      
Common Stock issued to vendors in exchange for services (in shares) [2]     5,625          
Net loss (12,154,446)           (12,154,446)  
Balance at the end at Jun. 30, 2022 19,070,499   $ 515   52,750,140   (33,680,156)  
Balance at the end (in shares) at Jun. 30, 2022 [2]     5,170,711          
Balance at the beginning at Dec. 31, 2021 $ 29,708,412   $ 506 507 51,233,616 51,233,615 (21,525,710)  
Balance at the beginning (in shares) at Dec. 31, 2021 5,074,932   5,074,932 [2]          
Share-based compensation $ 2,855,385       2,855,385      
Issuance of common stock upon vesting of restricted stock units 85   $ 21   64      
Issuance of common stock upon vesting of restricted stock units (in shares)     213,043          
Common Stock issued to vendors in exchange for services 38,627   $ 1   38,626      
Common Stock issued to vendors in exchange for services (in shares)     9,375          
Issuance of common stock upon exercise of stock options 206   $ 2   204      
Issuance of common stock upon exercise of stock options (in shares)     22,408          
Net loss (26,468,390)           (26,468,390)  
Balance at the end at Dec. 31, 2022 $ 6,134,325 $ 6,134,325 $ 532 $ 531 54,127,893 54,127,894 (47,994,100) $ (47,994,100)
Balance at the end (in shares) at Dec. 31, 2022 5,319,758   5,319,758 [2] 5,319,758        
Balance at the beginning at Mar. 31, 2022 $ 24,467,736   $ 506   51,482,604   (27,015,374)  
Balance at the beginning (in shares) at Mar. 31, 2022 [2]     5,074,932          
Share-based compensation 1,244,361       1,244,361      
Issuance of common stock upon vesting of restricted stock units 9   $ 9          
Issuance of common stock upon vesting of restricted stock units (in shares) [2]     90,154          
Common Stock issued to vendors in exchange for services 23,175       23,175      
Common Stock issued to vendors in exchange for services (in shares) [2]     5,625          
Net loss (6,664,782)           (6,664,782)  
Balance at the end at Jun. 30, 2022 19,070,499   $ 515   52,750,140   (33,680,156)  
Balance at the end (in shares) at Jun. 30, 2022 [2]     5,170,711          
Balance at the beginning at Dec. 31, 2022 $ 6,134,325 $ 6,134,325 $ 532 $ 531 54,127,893 $ 54,127,894 (47,994,100) $ (47,994,100)
Balance at the beginning (in shares) at Dec. 31, 2022 5,319,758   5,319,758 [2] 5,319,758        
Share-based compensation $ 1,115,372       1,115,372      
Issuance of common stock upon vesting of restricted stock units 3   $ 3          
Issuance of common stock upon vesting of restricted stock units (in shares) [2]     33,387          
Common Stock issued to vendors in exchange for services 79,130   $ 2   79,128      
Common Stock issued to vendors in exchange for services (in shares) [2]     25,000          
Issuance of common stock upon exercise of stock options 264   $ 3   261      
Issuance of common stock upon exercise of stock options (in shares) [2]     27,673          
Issuance of common stock in connection with public offering, net 6,431,615   $ 185   6,431,430      
Issuance of common stock in connection with public offering, net (in shares) [2]     1,850,000          
Net loss (16,429,469)           (16,429,469)  
Balance at the end at Jun. 30, 2023 $ (2,668,760)   $ 725   61,754,084   (64,423,569)  
Balance at the end (in shares) at Jun. 30, 2023 7,255,818   7,255,818 [2]          
Balance at the beginning at Mar. 31, 2023 $ (1,910,750)   $ 540   54,955,659   (56,866,949)  
Balance at the beginning (in shares) at Mar. 31, 2023 [2]     5,403,121          
Share-based compensation 366,995       366,995      
Issuance of common stock upon exercise of stock options (in shares) [2]     2,697          
Issuance of common stock in connection with public offering, net 6,431,615   $ 185   6,431,430      
Issuance of common stock in connection with public offering, net (in shares) [2]     1,850,000          
Net loss (7,556,620)           (7,556,620)  
Balance at the end at Jun. 30, 2023 $ (2,668,760)   $ 725   $ 61,754,084   $ (64,423,569)  
Balance at the end (in shares) at Jun. 30, 2023 7,255,818   7,255,818 [2]          
[1] Reflects 1-for-4 reverse stock split that became effective June 29, 2022. See Note 3 to the consolidated financial statements.
[2] Reflects 1-for-4 reverse stock split that became effective June 29, 2023. See Note 1 to the unaudited condensed consolidated financial statements.